EME:NYSEEMCOR Group, Inc. Analysis
Data as of 2026-06-18 - not real-time
$842.70
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
EMCOR Group (EME) trades at $842.7, comfortably above its 20‑day SMA (≈$833) but below the 50‑day SMA (≈$856), suggesting a short‑term pull‑back potential. Technicals show a neutral trend, an RSI of ~51 and a bullish MACD histogram (+$1.45) that supports modest upside toward the $879 resistance. The stock’s volatility is high at 33% over the past 30 days and beta exceeds 1.1, indicating sensitivity to market swings. Fundamentally, revenue is expanding at a robust 19.7% YoY, ROE is stellar at 39%, and the payout ratio is a conservative 3.9%, making the 0.16% dividend sustainable. However, the current price is well above the DCF‑derived fair value of $605 and the PE of 28 is modestly lower than the industry average of 31, implying the market is pricing in strong growth expectations. Recent coverage highlights EMCOR’s rapid growth in data‑center cooling and Oppenheimer’s new Outperform rating, reinforcing the growth narrative but also adding to valuation pressure.
Overall, while the company’s cash generation, low leverage and expanding infrastructure opportunities underpin a positive outlook, the elevated valuation, high volatility and decreasing volume suggest a cautious stance, especially in the near term.
Overall, while the company’s cash generation, low leverage and expanding infrastructure opportunities underpin a positive outlook, the elevated valuation, high volatility and decreasing volume suggest a cautious stance, especially in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with decreasing volume
- Bullish MACD histogram but neutral trend
- Overvaluation relative to DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth (~20% YoY) and high ROE
- Low payout ratio and sustainable dividend
- Positive analyst coverage and growth in data‑center cooling
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust cash flow and modest leverage
- Long‑term infrastructure and renewable energy demand
- Consistently high return metrics despite premium valuation
Key Metrics & Analysis
Financial Health
Revenue Growth19.70%
Profit Margin7.54%
P/E Ratio28.3
ROE39.23%
ROA11.75%
Debt/Equity13.36
P/B Ratio9.7
Op. Cash Flow$1.2B
Free Cash Flow$891.5M
Industry P/E31.5
Technical Analysis
TrendNeutral
RSI50.7
Support$775.88
Resistance$879.37
MA 20$833.04
MA 50$855.64
MA 200$725.43
MACDBullish
VolumeDecreasing
Fear & Greed Index91.13
Valuation
Fair Value$604.74
Target Price$1,000.14
Upside/Downside18.68%
GradeOvervalued
TypeBlend
Dividend Yield0.16%
Risk Assessment
Beta1.74
Volatility33.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.